GROENHUYSEN WILHELMUS CM 4
4 · NovoCure Ltd · Filed Jul 6, 2023
Insider Transaction Report
Form 4
NovoCure LtdNVCR
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Transactions
- Award
Ordinary Shares
[F1][F2]2023-06-30$35.28/sh+366$12,912→ 210,119 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January1, 2023 through June 30, 2023. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023.
Signature
Steven Robbins, as attorney in fact for Groenhuysen, Wilhelmus CM|2023-07-06